Alejandro Manosalva

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

Bijoy K. Menon, Brian Buck, Nishita Singh et al. · The Lancet · 2022 · 412 citations

Thrombosis, Cardiovascular Disease, Ischemic Stroke +14

Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial

Nishita Singh, Mohammed Almekhlafi, Fouzi Bala et al. · Stroke · 2023 · 28 citations

AcT Trial: Protocol for a Pragmatic Registry‐Linked Randomized Clinical Trial

Tolulope T. Sajobi, Nishita Singh, Mohammed Almekhlafi et al. · Stroke Vascular and Interventional Neurology · 2022 · 22 citations · Full text

Cerebrovascular Disease, Intravenous Thrombolysis, Intravenous Alteplase +24

Hashimoto Encephalopathy (Autoimmune Encephalitis)

Álvaro Sánchez Contreras, Adriana Rojas‐Villarraga, Alejandro Manosalva et al. · JCR Journal of Clinical Rheumatology · 2004 · 16 citations

Neuropsychology, Neurological Disorder, Corticobasal Degeneration +21

Alteplase Compared to Tenecteplase in patients with Acute Ischemic Stroke (AcT) Trial: Protocol for a Pragmatic Registry linked Randomized Clinical Trial

Tolulope T. Sajobi, Nishita Singh, Mohammed Almekhlafi et al. · Stroke Vascular and Interventional Neurology · 2022 · 12 citations · Full text

Randomized Clinical Trial, Cerebrovascular Disease, Intravenous Thrombolysis +19